Back
Unity Software Vs. Akero Therapeutics Industry Stock Comparison
Buy
57
U
Unity Software
Last Price:
$26.25
Seasonality Move:
13.89%
Buy
66
AKRO
Akero Therapeutics
Last Price:
$50.75
Seasonality Move:
22.68%
Buy
57
Unity Software (U)
is a Buy
Is Unity Software a Buy, Sell or Hold?
-
The current Unity Software [U] share price is $26.24. The Score for U is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
U is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
66
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $50.73. The Score for AKRO is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
U Stock Price Chart
What is Unity Software's stock price today?
-
The Unity Software share price today is $26.24Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and U is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $50.73Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
U Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.03 | Buy |
Relative Strength Index (14 RSI): | 66.92 | Buy |
Chaikin Money Flow: | 3718973 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.59 - 23.61) | Buy |
Bollinger Bands (100): | (19.66 - 23.98) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.07 | Buy |
Relative Strength Index (14 RSI): | 65.06 | Buy |
Chaikin Money Flow: | 1020714 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.36 - 47.66) | Buy |
Bollinger Bands (100): | (33.55 - 50.61) | Buy |
U Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.23 | Buy |
20-day SMA: | 22.22 | Buy |
50-day SMA: | 21.04 | Buy |
200-day SMA: | 21.45 | Buy |
8-day EMA: | 23.99 | Buy |
20-day EMA: | 22.66 | Buy |
50-day EMA: | 21.86 | Buy |
200-day EMA: | 22.07 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.93 | Buy |
20-day SMA: | 43.97 | Buy |
50-day SMA: | 41.79 | Buy |
200-day SMA: | 35.5 | Buy |
8-day EMA: | 47.54 | Buy |
20-day EMA: | 45.03 | Buy |
50-day EMA: | 43.07 | Buy |
200-day EMA: | 37.12 | Buy |
Unity Software Earnings Growth & U Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.12 per share, and an increase next year of $0.05 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and a decrease next year of $0.63 per share.
Unity Software Technical Analysis
May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |